Global Bronchoscopes Market Size, Share, Growth, 2034

(MENAFN- Straits Research) Bronchoscopes Market Size & Growth Analysis

The bronchoscopesmarket size was valued at USD 4.27 billion in 2025 and is projected to grow from USD 4.58 billion in 2026 to USD 8.13 billion by 2034 at a CAGR of 7.43% during the forecast period 2026–2034. North America dominated the bronchoscopes market with a share of 42.14% in 2025.

Bronchoscopes are flexible or rigid medical instruments used to view the inside of the airways and lungs. They help doctors diagnose and treat respiratory conditions by inserting a thin tube through the nose or mouth to examine bronchial passages, collect samples, and perform minimally invasive procedures safely and effectively.

The bronchoscopes market demand is driven by increasing respiratory diseases, lung cancer prevalence, and growing need for minimally invasive diagnostic procedures. Advancements in imaging technology, a rising geriatric population, and higher ICU admissions are driving adoption. Hospitals and clinics are increasingly investing in bronchoscopy systems for accurate airway examination and treatment procedures.

Key Takeaways

The North America bronchoscopesmarket accounted for a share of 42.14% in 2025. The Asia Pacific bronchoscopesmarket is expected to grow at a CAGR of 9.45% during the forecast period. By product, the flexible segment is expected to grow at a CAGR of 8.07% during the forecast period. By usage, the reusable segment is projected to grow at a CAGR of 7.93% during the forecast timeframe. By application, oncology held the largest market share of 37.22% in 2025. By end user, the ambulatory surgical centers segment is expected to grow at a CAGR of 9.04% during the forecast period. The US bronchoscopesmarket size was valued at USD 1.62 billion in 2025 and is projected to reach USD 1.74 billion in 2026.

Impact Of AI In Bronchoscopes Market

Artificial intelligence is transforming the bronchoscope market by enhancing diagnostic accuracy, real-time imaging, and procedural efficiency in respiratory care. AI-enabled bronchoscopy systems assist physicians in early lung disease detection, automated lesion recognition, and improved navigation during minimally invasive procedures. Integration of machine learning and computer vision is accelerating adoption across hospitals and diagnostic centers globally. The following companies are leveraging AI in bronchoscopy systems:

Olympus uses AI-powered endoscopy platforms such as EVIS X1 to enhance lesion detection and real-time image processing in bronchoscopy procedures. Medtronic has integrated AI-assisted navigation and lung mapping systems to improve bronchoscopy accuracy and biopsy guidance in complex pulmonary cases.

Bronchoscopes Market Trends

Expansion of Single-use Bronchoscopes for ICU Infection-Prevention Protocols

A key trend in the bronchoscopes market is the rapid adoption of single-use disposable bronchoscopes in intensive care and emergency respiratory units to eliminate cross-contamination risks. Hospitals are shifting away from reusable scopes due to persistent concerns over multidrug-resistant infections and ventilator-associated pneumonia. Devices from companies like Ambu A/S are increasingly integrated into ICU airway management protocols, especially for critically ill and immunocompromised patients. This shift is being reinforced by stricter hospital infection-control guidelines and expanded procedural use in emergency bronchoscopy for acute respiratory failure cases.

Shift toward Ultra-low Profile Flexible Bronchoscopes for Deep Airway Access

The bronchoscopes market is also witnessing a growing shift toward ultra-thin, highly flexible bronchoscopes designed to reach subsegmental and peripheral bronchi that were previously inaccessible with conventional systems. These devices integrate miniaturized CMOS imaging sensors and enhanced articulation mechanisms, enabling clearer visualization of small airway structures and more accurate tissue sampling in deep lung regions. This advancement is valuable in early lung cancer detection and interstitial lung disease assessment, where precision access is critical. Hospitals are increasingly combining these scopes with navigation platforms from Olympus Corporation to improve procedural accuracy, reduce sampling error, and expand minimally invasive diagnostic capability in complex pulmonary cases.

Bronchoscopes Market Investment And Funding Analysis

The bronchoscope market is experiencing rising investment and funding activity driven by increasing demand for AI-assisted bronchoscopy, robotic navigation systems, and minimally invasive pulmonary diagnostics. Funding is primarily focused on accelerating clinical trials, regulatory approvals, commercialization efforts, and expansion of next-generation imaging and navigation technologies for lung disease diagnosis and treatment. Following are some major funding activities undertaken by companies in 2025:

Key Funding Activities in Bronchoscopes Market, 2025

Company	Timeline	Activity	Focus	Value
Apreo Health	August 2025	Funding– Series B financing round	Advancement of pivotal clinical trials and commercialization of a bronchoscopy airway scaffold for severe emphysema, including minimally invasive interventional pulmonology solutions for COPD treatment	USD 130 million
Lynmou Medical	April 2025	Funding– Series A round	Development and global commercialization of flexible endoscopy systems, including AI-assisted imaging expansion for bronchoscopy-related applications	Over USD 2.5 million
Sotelix Endoscopy	February 2025	Investment– Seed funding round	R&D and in vivo testing of therapeutic endoscopy tools applicable to bronchoscopy and minimally invasive endoscopic procedures	USD 1.7 million

Market Summary

Market Metric	Details & Data (2025-2034)
2025 Market Valuation	USD 4.27 Billion
Estimated 2026 Value	USD 4.58 Billion
Projected 2034 Value	USD 8.13 Billion
CAGR (2026-2034)	7.43%
Study Period	2022-2034
Dominant Region	North America
Fastest Growing Region	Asia-Pacific
Key Market Players	Olympus Corporation (Japan), Boston Scientific Corporation (US), FUJIFILM Holdings Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark)

Download Free Sample Report to Get Detailed Insights.

Bronchoscopes Market Dynamics Market Drivers

Expansion of Robotic-assisted Peripheral Lung Biopsy and AI-based CT–Bronchoscopy Fusion Drives Market

The rising clinical shift toward robotic-assisted bronchoscopy is a key driver for diagnosing subcentimeter peripheral lung nodules that conventional scopes cannot reliably reach. Systems integrated with navigation platforms from Intuitive Surgical enable precise catheter steering and real-time lesion targeting in complex airway anatomy. This is increasingly used in early-stage lung cancer screening pathways, where CT-detected small nodules require minimally invasive biopsy confirmation, significantly increasing bronchoscopy utilization in interventional pulmonology suites.

AI-enabled CT–bronchoscopy fusion systems are improving precision in peripheral lung lesion localization by synchronizing pre-procedure CT imaging with real-time endoscopic navigation. This allows clinicians to accurately target small and hard-to-visualize nodules during biopsy, significantly reducing diagnostic uncertainty in early lung cancer pathways. The technology enhances procedural efficiency, shortens intervention time, and increases diagnostic yield in interventional pulmonology. Its growing integration into advanced respiratory care centers for subcentimeter lesions requiring highly precise minimally invasive confirmation is expanding bronchoscopy utilization, significantly driving bronchoscopes market growth.

Market Restraints

Shortage of Skilled Interventional Pulmonologists and High Maintenance Burden Restrain Market Growth

Limited availability of clinicians trained in robotic navigation bronchoscopy significantly restricts market expansion. Advanced systems require expertise in catheter steering, CT-to-endoscopy image fusion, and real-time peripheral lesion targeting, which are not yet standard in pulmonology training programs. This creates dependency on a small group of specialized interventional pulmonologists, reducing procedure throughput and increasing training burden on hospitals. The gap is more pronounced in non-tertiary and emerging healthcare facilities, slowing technology diffusion and limiting adoption of high-precision bronchoscopy platforms despite rising clinical demand.

High dependence on complex maintenance, calibration, and component replacement cycles for advanced bronchoscopy systems acts as a key restraint in the market. Robotic and high-definition video bronchoscopes require frequent servicing of imaging sensors, articulation mechanisms, and navigation modules to maintain diagnostic accuracy. Any technical downtime directly disrupts ICU and interventional pulmonology workflows, where rapid airway assessment is critical. Limited availability of authorized service networks and high spare-part costs further increase operational burden for hospitals, particularly in cost-sensitive healthcare systems, slowing continuous utilization and long-term adoption of advanced bronchoscopy platforms.

Market Opportunities

Shift Towards ASC-based Bronchoscopy and Growing Preference for Minimally Invasive Treatments Offer Growth Opportunities for Bronchoscopes Market Players

A growing shift toward ambulatory surgical centers for bronchoscopy procedures is creating a strong market opportunity for bronchoscope manufacturers, pulmonary device companies, and AI-assisted navigation system developers, driven by cost efficiency, shorter procedure times, and outpatient care preference. ASCs are increasingly adopting flexible and single-use bronchoscopes to perform diagnostic and minor therapeutic airway interventions outside traditional hospital settings. This transition reduces hospital burden while improving patient throughput and turnaround time. Rising payer support for outpatient respiratory diagnostics is further accelerating bronchoscopy decentralization, expanding access to minimally invasive pulmonary procedures in cost-sensitive healthcare environments globally.

The rising global burden of chronic respiratory diseases is creating significant opportunities for the bronchoscope market, driven by the need for early diagnosis and minimally invasive interventions. According to 2025 WHO-linked respiratory health data, over 80 million people in the WHO European Region suffer from chronic respiratory conditions, mainly COPD and asthma. This growing patient pool is increasing demand for advanced bronchoscopy procedures, enabling precise airway examination, improved disease management, and timely therapeutic interventions across healthcare systems worldwide.

Market Challenges

Reprocessing Complexity of Reusable Bronchoscopes and Delayed Detection of Respiratory Diseases Act as Challenges in Market

Flexible bronchoscopes require strict high-level disinfection protocols, and lapses in sterilization can increase the risk of cross-contamination and hospital-acquired infections, raising concerns among healthcare providers. Regulatory agencies such as the Food and Drug Administration have issued communications highlighting contamination risks associated with reprocessed endoscopes, including bronchoscopes, prompting manufacturers to invest in single-use variants and advanced automated reprocessing technologies to improve patient safety outcomes.

Delayed detection of respiratory diseases reduces the effectiveness of bronchoscopy adoption across healthcare systems. Many patients with lung cancer, tuberculosis, and COPD are diagnosed at advanced stages due to weak screening programs and low awareness at the primary care level. For example, WHO global respiratory updates highlight that late-stage lung cancer diagnoses remain common in several developing regions, limiting timely bronchoscopy intervention.

Bronchoscopes Market Regional Outlook North America: Market Dominance Led by Rapid Adoption of AI-enabled Bronchoscopy Systems and High Prevalence of Lung Cancer

The North America bronchoscopes market accounted for the largest regional share of 42.14% in 2025 due to advanced hospital infrastructure, rapid adoption of AI-enabled bronchoscopy systems, and strong integration of robotic-assisted pulmonary diagnostic platforms. High prevalence of lung cancer and COPD further drives procedure volumes across tertiary care centers. The presence of leading MedTech companies and early regulatory approvals for innovative endoscopy systems support continuous technology upgrades and widespread clinical adoption across the region.

US Bronchoscopes Market

The bronchoscopes market expansion in the US is led by the strong adoption of robotic bronchoscopy platforms and AI-based navigation systems in leading academic hospitals. Increasing utilization of navigation-guided biopsy procedures for early lung cancer detection is supporting demand. For example, Boston Scientific's bronchoscopy navigation technologies and Intuitive Surgical's Ion system are widely used in advanced pulmonology centers to improve diagnostic precision and reduce procedural risks, supported by strong reimbursement frameworks and clinical research initiatives.

Canada Bronchoscopes Market

The bronchoscopes market in Canada is fueled by rising focus on early respiratory disease screening programs and increasing adoption of single-use bronchoscopes in infection-sensitive hospital environments. Provincial healthcare systems are upgrading endoscopy infrastructure with minimally invasive diagnostic tools. For instance, hospitals in Canada are increasingly adopting Ambu single-use bronchoscopes to reduce cross-contamination risks, while expanding use of digital bronchoscopy systems to improve procedural efficiency and support safer airway management across public healthcare facilities.

Asia Pacific: Fastest Growth Driven by Rising Respiratory Disease Burden and Growing Emphasis on Minimally Invasive Lung Cancer Screening

The Asia Pacific bronchoscopes market is expected to grow at a CAGR of 9.45% during the forecast period, showcasing the fastest regional growth. This growth is fueled by rising respiratory disease burden and rapid modernization of pulmonary diagnostic infrastructure. Increasing adoption of AI-enabled bronchoscopy systems and robotic navigation tools is strengthening procedural accuracy across hospitals. For instance, hospitals in Australia and Singapore are integrating robotic bronchoscopy platforms for lung nodule diagnosis, while China is expanding EVIS X1-based advanced imaging systems in tertiary care centers to improve early lung cancer detection outcomes.

China Bronchoscopes Market

The bronchoscopes market ecosystem in China benefits from its large-scale healthcare modernization programs, rising lung cancer incidence, and strong uptake of advanced endoscopic technologies in major hospitals. For example, nationwide clinical surveys highlight widespread use of radial EBUS and navigational bronchoscopy in over 300 hospitals for peripheral lung lesion diagnosis. Additionally, tertiary hospitals in Shanghai and Beijing increasingly deploy AI-enhanced imaging systems to improve biopsy precision and early detection of respiratory diseases across high-patient-volume healthcare settings.

Singapore Bronchoscopes Market

The bronchoscopes market growth in Singapore is fueled by highly advanced healthcare infrastructure and early adoption of digital and AI-integrated endoscopy systems in leading public hospitals. Singapore's strong emphasis on minimally invasive lung cancer screening and integration of advanced imaging-guided bronchoscopy supports high utilization of precision-based pulmonary diagnostic technologies in specialized respiratory centers.

Bronchoscopes Market Segmentation Analysis By Product Type

By product, the rigid segment is expected to grow at a CAGR of 7.69% during the forecast period, due to strong utilization in therapeutic bronchoscopy procedures in foreign body removal, tumor debulking, and managing airway obstructions, where high precision and stability are required. Increasing demand in operating rooms and emergency interventions further supports its adoption.

The flexible segment is projected to grow at a CAGR of approximately 8.07% during the forecast period, driven by its widespread use in diagnostic bronchoscopy, higher patient comfort, and ability to access deeper bronchial pathways. Rising preference for minimally invasive procedures and growing use in early lung disease detection are further accelerating demand globally.

By Usage

Based on usage, the disposable segment is expected to grow at a CAGR of 8.14% during the forecast period due to rising preference for single-use devices in infection-sensitive bronchoscopy procedures. Increasing demand in ICU and emergency airway interventions and growing adoption in outpatient settings, where rapid procedure turnaround and elimination of sterilization steps are critical.

The reusable segment is projected to grow at a CAGR of 7.93% during the forecast period due to strong demand in tertiary care hospitals for high-precision diagnostic and therapeutic bronchoscopy and cost efficiency achieved through repeated sterilization and long-term use. Continued preference for advanced imaging performance in complex pulmonary disease management further supports segment growth.

By Application

Oncology accounted for the largest share of 37.22% in the bronchoscopes market, by packaging type in 2025. This dominance can be attributed to the rising prevalence of lung cancer worldwide and increasing demand for early and accurate tumor detection. Growing adoption of minimally invasive diagnostic techniques and advancements in AI-assisted imaging systems are further strengthening oncology's leading position in the market.

The ICU airway management segment is projected to grow at a CAGR of 8.56% during the forecast period, driven by increasing incidence of severe respiratory failure cases and rising hospital admissions due to COPD exacerbations, pneumonia, and acute respiratory distress. Growing need for rapid airway clearance and life-saving diagnostic procedures is further accelerating demand for advanced bronchoscopy.

By End User

By end user, hospitals accounted for a share of 72.88% in 2025 due to high patient inflow for respiratory disease management and availability of advanced bronchoscopy systems. Strong presence of skilled specialists, critical care facilities, and capability to handle complex diagnostic and therapeutic airway procedures further supported their dominance.

The ambulatory surgical centers segment is projected to grow at a CAGR of 9.04% during the forecast period due to rising demand for cost-effective outpatient bronchoscopy procedures. These centers offer shorter recovery times and reduced hospital stay burdens for patients. Increasing adoption of minimally invasive diagnostic and therapeutic airway interventions is further supporting their growth.

Competitive Landscape

The bronchoscope market landscape is moderately consolidated, with a few dominant global medical device manufacturers and several specialized endoscopy and surgical robotics companies competing across diagnostic and therapeutic segments. Established players such as multinational MedTech firms lead the market through strong R&D capabilities, regulatory approvals, and extensive hospital partnerships. The bronchoscopes market competition is driven by innovation in AI-assisted imaging, robotic bronchoscopy systems, and single-use flexible bronchoscopes. Emerging companies focus on niche technologies, cost-efficient devices, and software-integrated navigation platforms. Increasing demand for minimally invasive pulmonary procedures and early lung disease detection is further intensifying market competition globally.

List of Key and Emerging Players in Bronchoscopes Market

Olympus Corporation (Japan) Boston Scientific Corporation (US) FUJIFILM Holdings Corporation (Japan) KARL STORZ SE & Co. KG (Germany) Ambu A/S (Denmark) HOYA Corporation (Japan) Teleflex Incorporated (US) Medtronic plc (Ireland) Richard Wolf GmbH (Germany) Cook Medical (US) Smith & Nephew plc (UK) CONMED Corporation (US) Stryker Corporation (US) Braun Melsungen AG (Germany) Verathon Inc. (US) Cogentix Medical (US) Broncus Medical Inc. (US) NeoScope Inc. (US)

Recent Industry Developments

October 2025: PENTAX Medical signed an asset purchase agreement with Merit Medical Systems to divest its C2 CryoBalloon therapeutic endoscopy product line and strengthen strategic focus on core flexible reusable endoscopy operations.

September 2025: Olympus Corporation initiated a Class 1 device recall for its EVIS EXERA III bronchovideoscope and OES bronchofiberscope product lines to update safety instructions associated with laser and high-frequency therapy usage during bronchoscopy procedures.

August 2025: Body Vision Medical received pre-market approval from Singapore's Health Sciences Authority in for commercialization of its LungVision AI-powered bronchoscopy imaging platform in Singapore, supporting expansion of advanced lung cancer diagnostic technologies in Asia Pacific.

August 2025: Shanghai AnQing Medical Instrument Co., Ltd. received U.S. FDA 510(k) clearance for its Flexible Bronchoscope product portfolio, supporting international expansion of flexible bronchoscopy technologies.

August 2025: Zhejiang UE Medical Corp. obtained U.S. FDA 510(k) clearance for multiple UE BRONCHO single-use bronchoscopes and UE Display systems, expanding its disposable bronchoscopy product portfolio in the U.S. market.

Report Scope

Report Metric	Details
Market Size in 2025	USD 4.27 Billion
Market Size in 2026	USD 4.58 Billion
Market Size in 2034	USD 8.13 Billion
CAGR	7.43% (2026-2034)
Base Year for Estimation	2025
Historical Data	2022-2024
Forecast Period	2026-2034
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
Segments Covered	By Product, By Usage, Application, End User
Geographies Covered	North America, Europe, APAC, Middle East and Africa, LATAM
Countries Covered	US, Canada, UK, Germany, France, Spain, Italy, Russia, Nordic, Benelux, China, Korea, Japan, India, Australia, Taiwan, South East Asia, UAE, Turkey, Saudi Arabia, South Africa, Egypt, Nigeria, Brazil, Mexico, Argentina, Chile, Colombia

Download Free Sample Report to Get Detailed Insights.

Bronchoscopes Market Segments By Product

Rigid Flexible

By Usage

Disposable Reusable

Application

Oncology Pneumonia & Infectious Diagnosis ICU Airway Management Others

End User

Hospitals Ambulatory Surgical Centers Specialty Clinics

By Region

North America Europe APAC Middle East and Africa LATAM

MENAFN25052026004597010906ID1111162674